Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?
G Lisco, A De Tullio, O Disoteo… - Endocrine …, 2023 - ec.bioscientifica.com
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have changed considerably the
management of type 2 diabetes (T2D). However, recently published data from retrospective …
management of type 2 diabetes (T2D). However, recently published data from retrospective …
[PDF][PDF] Global, regional, and national thyroid cancer age-period-cohort modeling and Bayesian predictive modeling studies: A systematic analysis of the global burden …
J Chen, C Wang, B Shao - Heliyon, 2023 - cell.com
Objective To analyze the changing trend of the global burden of thyroid cancer (TC) and its
associated risk factors using data from the Global Burden of Disease study 2019 (GBD …
associated risk factors using data from the Global Burden of Disease study 2019 (GBD …
The American Thyroid Association risk stratification and long-term outcomes of differentiated thyroid cancer: a 20-year follow-up of patients in Saudi Arabia
AA Jammah, IM AlSadhan, EY Alyusuf… - Frontiers in …, 2023 - frontiersin.org
Background Studies have reported differing factors associated with poor outcomes in
patients with differentiated thyroid cancer (DTC). We aimed to describe our 20 years of …
patients with differentiated thyroid cancer (DTC). We aimed to describe our 20 years of …
Temporal trends of thyroid cancer between 2010 and 2019 in Asian countries by geographical region and SDI, comparison with global data
F Rezaei, A Mazidimoradi, Z Pasokh… - Aging …, 2023 - Wiley Online Library
Objective This study aims to describe temporal trends of thyroid cancer (ThC) from 2010 to
2019, in Asian countries by geographical region and sociodemographic index, compared …
2019, in Asian countries by geographical region and sociodemographic index, compared …